Literature DB >> 11583680

5-S-cysteinyldopa as diagnostic tumor marker for uveal malignant melanoma.

H Goto1, M Usui, K Wakamatsu, S Ito.   

Abstract

PURPOSE: To evaluate the clinical significance of 5-S-cysteinyldopa (5-S-CD), a major intermediate in melanin synthesis, as a potential diagnostic tumor marker for uveal malignant melanoma.
METHODS: The levels of 5-S-CD in the serum were measured by high-performance liquid chromatography in 16 patients with primary uveal melanoma. The levels of 5-S-CD were also measured in both aqueous and vitreous humor in 10 patients with uveal melanoma. The serum of healthy volunteers and patients with skin diseases other than melanoma, and the intraocular fluids of patients with cataract and vitreoretinal diseases were used as controls.
RESULTS: Serum concentrations of 5-S-CD in patients with uveal melanoma in the absence of extraocular metastases were close to those of controls; however, serum concentrations of 5-S-CD were significantly elevated in patients with extraocular metastases of melanoma. Concentrations of 5-S-CD in the intraocular fluids, especially vitreous humor, were higher in patients with uveal melanoma than in controls.
CONCLUSIONS: 5-S-CD in intraocular fluids may serve as a useful biochemical marker for the diagnosis of uveal melanoma. Serum 5-S-CD may contribute to the assessment of the presence and progression of extraocular metastases in patients with uveal melanoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583680     DOI: 10.1016/s0021-5155(01)00393-8

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  5 in total

1.  Treatment of large conjunctival nevus by resection and reconstruction using amniotic membrane.

Authors:  Machiko Tomita; Hiroshi Goto; Ryuji Muramatsu; Masahiko Usui
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-11-29       Impact factor: 3.117

Review 2.  Vitreous diagnosis in neoplastic diseases.

Authors:  Mónica Asencio-Duran; José Luis Vallejo-Garcia; Natalia Pastora-Salvador; Agustín Fonseca-Sandomingo; Mario R Romano
Journal:  Mediators Inflamm       Date:  2012-09-26       Impact factor: 4.711

Review 3.  Blood biomarkers for uveal melanoma.

Authors:  Pierre L Triozzi; Arun D Singh
Journal:  Future Oncol       Date:  2012-02       Impact factor: 3.674

Review 4.  Significance of 5-S-Cysteinyldopa as a Marker for Melanoma.

Authors:  Kazumasa Wakamatsu; Satoshi Fukushima; Akane Minagawa; Toshikazu Omodaka; Tokimasa Hida; Naohito Hatta; Minoru Takata; Hisashi Uhara; Ryuhei Okuyama; Hironobu Ihn
Journal:  Int J Mol Sci       Date:  2020-01-09       Impact factor: 5.923

5.  Evaluation of melanogenesis in A-375 melanoma cells treated with 5,7-dimethoxycoumarin and valproic acid.

Authors:  Ewa Chodurek; Arkadiusz Orchel; Joanna Orchel; Sławomir Kurkiewicz; Natalia Gawlik; Zofia Dzierżewicz; Krystyna Stępień
Journal:  Cell Mol Biol Lett       Date:  2012-09-20       Impact factor: 5.787

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.